S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
The Next Big Crisis Is Here (Ad)
MarketBeat Week in Review – 1/23- 1/27
Visa, L3Harris rise; Intel, Eastman Chemical fall
The Next Big Crisis Is Here (Ad)
How major US stock indexes fared Friday 1/27/2023
Closing prices for crude oil, gold and other commodities
Is This The End of Capitalism? (Ad)
Lots of sound and fury on US debt, but not a crisis — yet
Wall Street adds more to its big January after strong week
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
The Next Big Crisis Is Here (Ad)
MarketBeat Week in Review – 1/23- 1/27
Visa, L3Harris rise; Intel, Eastman Chemical fall
The Next Big Crisis Is Here (Ad)
How major US stock indexes fared Friday 1/27/2023
Closing prices for crude oil, gold and other commodities
Is This The End of Capitalism? (Ad)
Lots of sound and fury on US debt, but not a crisis — yet
Wall Street adds more to its big January after strong week
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
The Next Big Crisis Is Here (Ad)
MarketBeat Week in Review – 1/23- 1/27
Visa, L3Harris rise; Intel, Eastman Chemical fall
The Next Big Crisis Is Here (Ad)
How major US stock indexes fared Friday 1/27/2023
Closing prices for crude oil, gold and other commodities
Is This The End of Capitalism? (Ad)
Lots of sound and fury on US debt, but not a crisis — yet
Wall Street adds more to its big January after strong week
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
The Next Big Crisis Is Here (Ad)
MarketBeat Week in Review – 1/23- 1/27
Visa, L3Harris rise; Intel, Eastman Chemical fall
The Next Big Crisis Is Here (Ad)
How major US stock indexes fared Friday 1/27/2023
Closing prices for crude oil, gold and other commodities
Is This The End of Capitalism? (Ad)
Lots of sound and fury on US debt, but not a crisis — yet
Wall Street adds more to its big January after strong week
NASDAQ:MEIP

MEI Pharma - MEIP Stock Forecast, Price & News

$0.31
-0.02 (-6.08%)
(As of 01/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.31
$0.32
50-Day Range
$0.22
$0.41
52-Week Range
$0.21
$2.21
Volume
483,419 shs
Average Volume
507,347 shs
Market Capitalization
$41.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.86

MEI Pharma MarketRank™ Forecast

Analyst Rating
Hold
2.17 Rating Score
Upside/​Downside
824.0% Upside
$2.86 Price Target
Short Interest
Healthy
3.42% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.85
Upright™ Environmental Score
News Sentiment
0.22mentions of MEI Pharma in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.52) to ($0.40) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.18 out of 5 stars

Medical Sector

465th out of 1,055 stocks

Pharmaceutical Preparations Industry

224th out of 519 stocks


MEIP stock logo

About MEI Pharma (NASDAQ:MEIP) Stock

MEI Pharma, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical compounds. Its products include Zandelisib, Voruciclib, and ME-344. The company was founded on December 1, 2000 and is headquartered in San Diego, CA.

Receive MEIP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MEI Pharma and its competitors with MarketBeat's FREE daily newsletter.

MEIP Stock News Headlines

MEI Pharma (NASDAQ:MEIP) Now Covered by StockNews.com
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
MEI Pharma Initiates Strategic Realignment
MEI Pharma First Quarter 2023 Earnings: Beats Expectations
Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
MEI Pharma, Inc. (MEIP)
MEI Pharma Announces Changes to Board of Directors
MEI Pharma stock trades higher as FY22 revenue grows 17%
MEI Pharma, Inc. (MEIP) Q4 2022 Earnings Call Transcript
1MEIP : Earnings Outlook For MEI Pharma
GreenWood Investors Second Quarter 2022 Letter
See More Headlines
Receive MEIP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MEI Pharma and its competitors with MarketBeat's FREE daily newsletter.

MEIP Company Calendar

Last Earnings
11/14/2022
Today
1/28/2023
Next Earnings (Estimated)
2/09/2023
Fiscal Year End
6/30/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:MEIP
Previous Symbol
NASDAQ:MSHL
Employees
76
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$2.86
High Stock Price Forecast
$5.00
Low Stock Price Forecast
$1.00
Forecasted Upside/Downside
+824.0%
Consensus Rating
Hold
Rating Score (0-4)
2.17
Research Coverage
6 Analysts

Profitability

Net Income
$-54,450,000.00
Pretax Margin
-111.46%

Debt

Sales & Book Value

Annual Sales
$40.70 million
Book Value
$0.39 per share

Miscellaneous

Free Float
125,052,000
Market Cap
$41.20 million
Optionable
Optionable
Beta
0.93

Key Executives

  • Daniel P. Gold
    President, Chief Executive Officer & Director
  • David M. Urso
    Chief Operating Officer & General Counsel
  • Brian G. Drazba
    Chief Financial Officer & Secretary
  • Richard G. Ghalie
    Chief Medical Officer
  • Benjamin Cadieux
    Vice President-Medical Affairs













MEIP Stock - Frequently Asked Questions

Should I buy or sell MEI Pharma stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MEI Pharma in the last year. There are currently 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" MEIP shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MEIP, but not buy additional shares or sell existing shares.
View MEIP analyst ratings
or view top-rated stocks.

What is MEI Pharma's stock price forecast for 2023?

6 Wall Street research analysts have issued 1 year target prices for MEI Pharma's stock. Their MEIP share price forecasts range from $1.00 to $5.00. On average, they expect the company's stock price to reach $2.86 in the next twelve months. This suggests a possible upside of 824.0% from the stock's current price.
View analysts price targets for MEIP
or view top-rated stocks among Wall Street analysts.

How have MEIP shares performed in 2023?

MEI Pharma's stock was trading at $0.2436 at the beginning of the year. Since then, MEIP stock has increased by 26.9% and is now trading at $0.3092.
View the best growth stocks for 2023 here
.

Are investors shorting MEI Pharma?

MEI Pharma saw a increase in short interest in the month of January. As of January 15th, there was short interest totaling 4,560,000 shares, an increase of 19.4% from the December 31st total of 3,820,000 shares. Based on an average trading volume of 1,270,000 shares, the days-to-cover ratio is presently 3.6 days.
View MEI Pharma's Short Interest
.

When is MEI Pharma's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 9th 2023.
View our MEIP earnings forecast
.

How were MEI Pharma's earnings last quarter?

MEI Pharma, Inc. (NASDAQ:MEIP) posted its earnings results on Monday, November, 14th. The company reported ($0.13) EPS for the quarter, hitting analysts' consensus estimates of ($0.13). The firm earned $8.73 million during the quarter, compared to analysts' expectations of $9.75 million. MEI Pharma had a negative net margin of 98.17% and a negative trailing twelve-month return on equity of 115.15%.

What other stocks do shareholders of MEI Pharma own?
What is MEI Pharma's stock symbol?

MEI Pharma trades on the NASDAQ under the ticker symbol "MEIP."

How do I buy shares of MEI Pharma?

Shares of MEIP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is MEI Pharma's stock price today?

One share of MEIP stock can currently be purchased for approximately $0.31.

How much money does MEI Pharma make?

MEI Pharma (NASDAQ:MEIP) has a market capitalization of $41.20 million and generates $40.70 million in revenue each year. The company earns $-54,450,000.00 in net income (profit) each year or ($0.40) on an earnings per share basis.

How can I contact MEI Pharma?

MEI Pharma's mailing address is 11455 EL CAMINO REAL SUITE 250, SAN DIEGO CA, 92130. The official website for the company is www.meipharma.com. The company can be reached via phone at (858) 369-7100, via email at investor@meipharma.com, or via fax at 302-655-5049.

This page (NASDAQ:MEIP) was last updated on 1/28/2023 by MarketBeat.com Staff